Therapeutic effects of ruxolitinib in patients with myelofibrosis without clinically significant splenomegaly

Ohad Benjamini; Preetesh Jain; Zeev Estrov; Hagop M. Kantarjian; Srdan Verstovsek

doi:10.1182/blood-2012-07-446849

Therapeutic effects of ruxolitinib in patients with myelofibrosis without clinically significant splenomegaly

Ohad Benjamini
, Preetesh Jain
, Zeev Estrov
, Hagop M. Kantarjian
, Srdan Verstovsek^*

^*Corresponding author for this work

University of Texas MD Anderson Cancer Center

Research output: Contribution to journal › Letter › peer-review

18 Scopus citations

Original language	English
Pages (from-to)	2768-2769
Number of pages	2
Journal	Blood
Volume	120
Issue number	13
DOIs	https://doi.org/10.1182/blood-2012-07-446849
State	Published - 27 Sep 2012
Externally published	Yes

Funding

Funders	Funder number
National Cancer Institute	P30CA016672

Access to Document

10.1182/blood-2012-07-446849

Cite this

@article{38d6cdacbdca4912aa0c6e0126e0e6a5,

title = "Therapeutic effects of ruxolitinib in patients with myelofibrosis without clinically significant splenomegaly",

author = "Ohad Benjamini and Preetesh Jain and Zeev Estrov and Kantarjian, \{Hagop M.\} and Srdan Verstovsek",

year = "2012",

month = sep,

day = "27",

doi = "10.1182/blood-2012-07-446849",

language = "אנגלית",

volume = "120",

pages = "2768--2769",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "13",

}

TY - JOUR

T1 - Therapeutic effects of ruxolitinib in patients with myelofibrosis without clinically significant splenomegaly

AU - Benjamini, Ohad

AU - Jain, Preetesh

AU - Estrov, Zeev

AU - Kantarjian, Hagop M.

AU - Verstovsek, Srdan

PY - 2012/9/27

Y1 - 2012/9/27

UR - https://www.scopus.com/pages/publications/84866874484

U2 - 10.1182/blood-2012-07-446849

DO - 10.1182/blood-2012-07-446849

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 23019204

AN - SCOPUS:84866874484

SN - 0006-4971

VL - 120

SP - 2768

EP - 2769

JO - Blood

JF - Blood

IS - 13

ER -

Therapeutic effects of ruxolitinib in patients with myelofibrosis without clinically significant splenomegaly

Funding

Access to Document

Other files and links

Cite this